Mission Wealth Management LP Purchases 668 Shares of Thermo Fisher Scientific Inc. (NYSE:TMO)

Mission Wealth Management LP grew its holdings in shares of Thermo Fisher Scientific Inc. (NYSE:TMO - Free Report) by 15.2% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 5,051 shares of the medical research company's stock after acquiring an additional 668 shares during the quarter. Mission Wealth Management LP's holdings in Thermo Fisher Scientific were worth $2,514,000 at the end of the most recent quarter.

A number of other institutional investors also recently made changes to their positions in TMO. Bernard Wealth Management Corp. bought a new position in shares of Thermo Fisher Scientific during the fourth quarter valued at about $25,000. FPC Investment Advisory Inc. bought a new position in Thermo Fisher Scientific during the 4th quarter worth approximately $28,000. Pillar Financial Advisors LLC bought a new stake in Thermo Fisher Scientific in the fourth quarter valued at approximately $29,000. Ameriflex Group Inc. bought a new position in shares of Thermo Fisher Scientific in the fourth quarter worth approximately $30,000. Finally, Noble Wealth Management PBC bought a new stake in Thermo Fisher Scientific during the 4th quarter valued at $35,000. Hedge funds and other institutional investors own 89.23% of the company's stock.

Analysts Set New Price Targets

Several equities analysts have recently commented on TMO shares. UBS Group lowered their price objective on shares of Thermo Fisher Scientific from $715.00 to $500.00 and set a "buy" rating for the company in a research note on Thursday, April 24th. Wells Fargo & Company dropped their price objective on Thermo Fisher Scientific from $580.00 to $570.00 and set an "overweight" rating for the company in a report on Thursday, April 24th. Royal Bank of Canada reduced their target price on Thermo Fisher Scientific from $651.00 to $637.00 and set an "outperform" rating on the stock in a research note on Thursday, April 24th. Evercore ISI dropped their price target on Thermo Fisher Scientific from $585.00 to $500.00 and set an "outperform" rating for the company in a research note on Thursday, April 24th. Finally, Wall Street Zen upgraded shares of Thermo Fisher Scientific from a "hold" rating to a "buy" rating in a report on Wednesday, May 21st. Four research analysts have rated the stock with a hold rating and seventeen have issued a buy rating to the company. Based on data from MarketBeat, Thermo Fisher Scientific currently has a consensus rating of "Moderate Buy" and a consensus target price of $605.30.

Insider Buying and Selling at Thermo Fisher Scientific

In other Thermo Fisher Scientific news, EVP Gianluca Pettiti sold 300 shares of the company's stock in a transaction dated Monday, April 28th. The shares were sold at an average price of $429.93, for a total transaction of $128,979.00. Following the transaction, the executive vice president now owns 23,167 shares in the company, valued at approximately $9,960,188.31. This represents a 1.28% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 0.33% of the company's stock.

Thermo Fisher Scientific Stock Up 0.6%

Shares of NYSE:TMO opened at $405.15 on Tuesday. Thermo Fisher Scientific Inc. has a 12-month low of $390.50 and a 12-month high of $627.88. The stock has a market capitalization of $152.94 billion, a price-to-earnings ratio of 24.51, a PEG ratio of 2.99 and a beta of 0.78. The stock has a fifty day simple moving average of $416.55 and a two-hundred day simple moving average of $491.11. The company has a current ratio of 1.66, a quick ratio of 1.29 and a debt-to-equity ratio of 0.59.

Thermo Fisher Scientific (NYSE:TMO - Get Free Report) last announced its quarterly earnings results on Wednesday, April 23rd. The medical research company reported $5.15 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $5.10 by $0.05. The company had revenue of $10.36 billion for the quarter, compared to analysts' expectations of $10.23 billion. Thermo Fisher Scientific had a net margin of 14.78% and a return on equity of 17.51%. Thermo Fisher Scientific's revenue was up .2% compared to the same quarter last year. During the same quarter in the previous year, the business posted $5.11 EPS. On average, research analysts anticipate that Thermo Fisher Scientific Inc. will post 23.28 earnings per share for the current fiscal year.

Thermo Fisher Scientific Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, July 15th. Investors of record on Friday, June 13th will be given a $0.43 dividend. The ex-dividend date is Friday, June 13th. This represents a $1.72 annualized dividend and a yield of 0.42%. Thermo Fisher Scientific's dividend payout ratio (DPR) is presently 10.09%.

Thermo Fisher Scientific Profile

Thermo Fisher Scientific Inc provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.